Effects of constitutive deletion of opioid receptors on the basal densities of Fas and Fas-associated protein with death domain (FADD) in the mouse brain: A δ-opioid tone inhibits FADD

European Neuropsychopharmacology

Volumn 17, Issue 5, 2007, Pages 366-374

  García Fuster, M Julia ^a   Ferrer Alcón, Marcelino ^a   Martín, Miquel ^b   Kieffer, Brigitte L ^c   Maldonado, Rafael ^b   García Sevilla, Jesús A ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

, and opioid receptor KO mice; ; Endogenous opioid tone; ; FADD protein; ; Fas receptor; ; Mouse brain; Phosphorylated FADD (Ser191);

Indexed keywords

DELTA OPIATE RECEPTOR; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; GENOTYPE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANIMALS; ANTIGENS, CD95; BRAIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, OPIOID; SERINE;

EID: 33847179518     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2006.08.008     Document Type: Article

References (52)

1. Audet N., Paquin-Gobeil M., Landry-Paquet O., Schiller P.W., and Piñeyro G. Internalization and Src activity regulate the time course of ERK activation by delta opioid receptor ligands. J. Biol. Chem. 280 (2005) 7808-7816
2. Alappat E., Feig C., Boyerinas B., Volkland J., Samuels M., Murmann A.E., Thorburn A., Kidd V.J., Slaughter C.A., Osborn S.L., Winoto A., Tang W.J., and Peter M.E. Phosphorylation of FADD at serine 194 by CKIα regulates its nonapoptotic activities. Mol. Cell 19 (2005) 321-332
3. Algeciras-Schimnich A., Shen L., Barnhart B.C., Murmann A.E., Burkhardt J.K., and Peter M.E. Molecular ordering of the initial signaling events of CD95. Mol. Cell. Biol. 22 (2002) 207-220
4. Ammon S., Mayer P., Riechert U., Tischmeyer H., and Höllt V. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Mol. Brain Res. 112 (2003) 113-125
5. Barry U., and Zuo Z. Opioids: old drugs for potential new applications. Curr. Pharm. Des. 11 (2005) 1343-1350
6. Bechmann I., Mor G., Nilsen J., Eliza M., Nitsch R., and Naftolin F. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain. Glia 27 (1999) 62-74
7. Boronat M.A., García-Fuster M.J., and García-Sevilla J.A. Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain. Br. J. Pharmacol. 134 (2001) 1263-1270
8. Budd R.C. Death receptors couple to both cell proliferation and apoptosis. J. Clin. Invest. 109 (2002) 437-442
9. Chefer V.I., Kieffer B.L., and Shippenberg T.S. Contrasting effects of μ opioid receptor and δ opioid receptor deletion upon the behavioral and neurochemical effects of cocaine. Neuroscience 127 (2004) 497-503
10. Chefer V.I., Czyzyk T., Bolan E.A., Moron J., Pintar J.E., and Shippenberg T.S. Endogenous κ-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. J. Neurosci. 25 (2005) 5029-5037
11. Contet C., Gavériaux-Ruff C., Matifas A., Caradec C., Champy M.-F., and Kieffer B.L. Dissociation of analgesic and hormonal responses to forced swim stress using opioid receptor knockout mice. Neurospsychopharmacology 31 (2006) 1733-1744
12. Desbarats J., Birge R.B., Minouni-Rongy M., Weistein D.E., Palerme J.S., and Newell M.K. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 5 (2003) 118-125
13. Filliol D., Ghozland S., Chluba J., Martín M., Matthes H.W., Simonin F., Befort K., Gavériaux-Ruff C., Dierich A., LeMeur M., Valverde O., Maldonado R., and Kieffer B.L. Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses. Nat. Genet. 25 (2000) 195-200
14. García-Fuster M.J., Ferrer-Alcón M., Miralles A., and García-Sevilla J.A. Modulation of Fas receptor proteins and dynamin during opiate addiction and induction of opiate withdrawal in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 368 (2003) 421-431
15. García-Fuster M.J., Ferrer-Alcón M., Miralles A., and García-Sevilla J.A. Deglycosylation of Fas receptor and chronic morphine treatment up-regulate high molecular mass Fas aggregates in the rat brain. Eur. J. Pharmacol. 496 (2004) 63-69
16. García-Fuster M.J., Miralles A., Martín M., Maldonado R., and García-Sevilla J.A. Fas receptor and Fas-associated death domain (FADD) in the cerebral cortex of μ-, δ-, or κ-opioid receptor knock-out mice. Methods Find. Exp. Clin. Pharmacol. 26 Suppl. A (2004) 78
17. García-Fuster, M.J., Miralles, A., García-Sevilla, J.A., in press. Effects of opiate drugs on Fas-associated protein with death domain (FADD) and effector caspases in the rat brain: regulation by the ERK1/2 MAP kinase pathway. Neuropsychopharmacology. Advance online publication: 8 February 2006, doi:10.1038/sj.npp.1301040.
18. García-Sevilla J.A., Ferrer-Alcón M., Martín M., Kieffer B.L., and Maldonado R. Neurofilament proteins and cAMP pathway in brains of μ-, δ- or κ-opioid receptor gene knock-out mice: effects of chronic morphine administration. Neuropharmacology 46 (2004) 519-530
19. Gomes I., Gupta A., Filipovska J., Szeto H.H., Pintar J.E., and Devi L.A. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 5135-5139
20. Hauser K.F., Houdi A.A., Turbek C.S., Elde R.P., and Maxson III W. Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of μ and δ receptor activation on proliferation and neurite elongation. Eur. J. Neurosci. 12 (2000) 1281-1293
21. Holmström T.H., Tran S.E.F., Johnson V.L., Ahn N.G., Chow S.C., and Eriksson J.E. Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis. Mol. Cell. Biol. 19 (1999) 5991-6002
22. Hu S., Sheng W.S., Lokensgard J.R., and Peterson P.K. Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 42 (2002) 829-836
23. Kieffer B.L., and Gavériaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66 (2002) 285-306
24. Lambert C., Landau A.M., and Desbarats J. Fas-beyond death: a regenerative role for Fas in the nervous system. Apoptosis 8 (2003) 551-562
25. Le Guen S., Gestreau C., and Besson J.-M. Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system. Eur. J. Neurosci. 17 (2003) 2425-2437
26. Liao D., Lin H., Law P.Y., and Loh H.H. Mu-opioid receptors modulate the stability of dendritic spines. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1725-1730
27. Lüschen S., Falk M., Scherer G., Ussat S., Paulsen M., and Adam-Klages S. The Fas-associated death domain protein/caspase-8/c-FLIP signaling pathway is involved in TNF-induced activation of ERK. Exp. Cell Res. 310 (2005) 33-42
28. Ma M.C., Qian H., Ghassemi F., Zhao P., and Xia Y. Oxygen-sensitive delta-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J. Biol. Chem. 280 (2005) 16208-16218
29. Marie-Claire C., Courtin C., Roques B.P., and Noble F. Cytoskeletal genes regulation by chronic morphine treatment in rat striatum. Neuropsychopharmacology 29 (2004) 2208-2215
30. Martin M., Matifas A., Maldonado R., and Kieffer B.L. Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones. Eur. J. Neurosci. 17 (2003) 701-708
31. Matthes H.W.D., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., and Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature 383 (1996) 819-823
32. Matthes H.W.D., Smadja C., Valverde O., Vonesch J.L., Foutz A.S., Boudinot E., Denavit-Saubié M., Severini C., Negri L., Roques B.P., Maldonado R., and Kieffer B.L. Activity of the δ-opioid receptor is partially reduced, whereas activity of the κ-receptor is maintained in mice lacking the μ-receptor. J. Neurosci. 18 (1998) 7285-7295
33. Nadal X., Baños J.-E., Kieffer B.L., and Maldonado R. Neuropathic pain is enhanced in δ-opioid receptor knockout mice. Eur. J. Neurosci. 23 (2006) 830-834
34. Narita M., Kuzumaki N., Miyatake M., Sato F., Wachi H., Seyama Y., and Suzuki T. Role of δ-opioid receptor function in neurogenesis and neuroprotection. J. Neurochem. 97 (2006) 1494-1505
35. Pérez-San Emeterio E., Tramullas M., and Hurlé M.A. Modulation of apoptosis in the mouse brain after morphine treatments and morphine withdrawal. J. Neurosci. Res. 83 (2006) 1352-1361
36. Perrine S.A., Hoshaw B.A., and Unterwald E.M. Delta opioid receptor ligands modulate anxiety-like behaviors in the rat. Br. J. Pharmacol. 147 (2006) 864-872
37. Sastry P.S., and Rao K.S. Apoptosis and the nervous system. J. Neurochem. 74 (2000) 1-20
38. Sharma K., Wang R.X., Zhang L.Y., Yin D.L., Luo X.Y., Solomon J.C., Jiang R.F., Markos K., Davidson W., Scott D.W., and Shi Y.F. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol. Ther. 88 (2000) 333-347
39. Simonin F., Valverde O., Smadja C., Slowe S., Kitchen I., Dierich A., Le Meur M., Roques B.P., Maldonado R., and Kieffer B.L. Disruption of the κ-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ-agonist U-50,488H and attenuates morphine withdrawal. EMBO J. 17 (1998) 886-897
40. Tegeder I., and Geisslinger G. Opioids as modulators of cell death and survival-unraveling mechanisms and revealing new indications. Pharmacol. Rev. 56 (2004) 351-369
41. Tibbetts M.D., Zheng L., and Lenardo M.J. The death effector domain protein family: regulators of cellular homeostasis. Nat. Immunol. 4 (2003) 404-409
42. Traynor J.R., and Elliot J. δ-Opioid receptor subtypes and cross talk with μ-receptors. Trends Pharmacol. Sci. 14 (1993) 84-85
43. Tourneur L., Buzyn A., and Chiocchia G. FADD adaptor in cancer. Med. Immunol. 4 (2005) 1-9
44. 5]enkephalin blocks Bax-related apoptotic processes. Eur. J. Pharmacol. 428 (2001) 149-151
45. Valjent E., Corvol J.-C., Trzaskos J.M., Girault J.-A., and Hervé D. Role of the ERK pathway in psychostimulant-induced locomotor sensitization. BMC Neurosci. 7 (2006) 20 10.1186/1471-2202-7-20
46. Wada T., and Penninger J.M. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23 (2004) 2838-2849
47. Wang J., Charboneau R., Barke R.A., Loh H.H., and Roy S. μ-Opioid receptor mediates chronic restraint stress-induced lymphocyte apoptosis. J. Immunol. 169 (2002) 3630-3636
48. Watanabe-Fukunaga R., Brannan C.I., Itoh N., Yonehara S., Copeland N.G., Jenkins N.A., and Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148 (1992) 1274-1279
49. Zhang J., Haddad G.G., and Xia Y. Delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. Brain Res. 885 (2000) 143-153
50. Zhang J., Gibney G.T., Zhao P., and Xia Y. Neuroprotective role of delta-opioid receptors in cortical neurons. Am. J. Physiol., Cell Physiol. 282 (2002) C1225-C1234
51. Zhang J., Zhang D., and Hua Z. FADD and its phosphorylation. IUBMB Life 56 (2004) 395-401
52. Zuliani C., Kleber S., Klussmann S., Wenger T., Kenzelmann M., Schreglmann N., Martínez A., del Río J.A., Soriano E., Vodrazka P., Kuner R., Groene H.J., Herr I., Krammer P.H., and Martín-Villalba A. Control of neuronal branching by the death receptor CD95 (Fas/Apo-1). Cell Death Differ. 13 (2006) 31-40